to Content

Dr. Edison Tak-Bun LIU Executive Director, Singapore Cancer Syndicate and Genome Institute of Singapore


1969-1973 Stanford University, B.S. Chemistry, Psychology
1973-1978 Stanford University, M.D
1985-1987 Instructor, Department of Medicine, Division of Oncology (University of California at San Francisco)
1987-1993 Assistant Professor in Medicine and Oncology, School of Medicine University of North Carolina at Chapel Hill
1988-1993 Director Preleukemic Clinic, North Carolina Memorial Hospital
1993-1996 Leader, Breast Cancer Program, Lineberger Comprehensive Cancer Center
1996-2001 Director, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD
  Division of Clinical Sciences, National Cancer Institute
1997-2001 Chief, Molecular Signaling and Oncogenesis Section, Department of Cell and Cancer Biology, Medicine Branch,
2001-present Executive Director, Genome Institute of Singapore
2001-present Professor of Medicine, National University of Singapore, Special Advisor to the Vice Chancellor
2001-present Professor, Department of Community, Occupational and Family Medicine (COFM), National University of Singapore
2002-present Executive Director, Singapore Tissue Network
2003-present Executive Director, Singapore Cancer Syndicate (funding-agency)
2005-present Adjunct Professor of Molecular and Cellular Biology at the University of Champaign-Urbana.


American Federation for Clinical Research
American Association for the Advancement of Science
American Society of Hematology
American Society for Clinical Investigation (elected)
Cancer and Leukemia Group B: Chair, Solid Tumor Correlative Sciences-Committee, resigned 1996
American Association for Cancer Research, Clinical Cancer Research Committee, resigned 2000
American Association for Cancer Research, Board of Directors, elected 2000-2002
American Association for Cancer Research, AACR International Affairs Committee, 2002-2005
International Genetics Federation, Board of Advisors, 2003


An Introduction to the Concept of Cancer Genes, Springer-Verlag, 1988
The Role of ras Gene Mutations in Myeloproliferative Disorders, in: Myeloproliferative Disorders. Clinics in Laboratory Medicine, W.B. Saunders Co, 1989
Breast Cancer Research: Where we are and where we should go, Breast Cancer Research, 2000
Defining the Galaxy of Gene Expression in Breast Cancer, Breast Cancer Research, 2002
Oncogenes and Suppressor Genes: Genetic Control of Cancer, in: Cecil Textbook of Medicine (22st Edition), W.B. Saunders, 2003
Expression genomics and drug development: towards predictive pharmacology. Brief Funct Genomic Proteomic, 2005


Clinical Investigator Award, National Cancer Institute, 1985-1988
Brinker International Award for Breast Cancer Research, 1996
Rosenthal Award, AACR: for the discovery that HER-2 status determines response to adjuvant chemotherapy with doxorubicin, 2000
Public Service Medal (National Day, 2003): for work in controlling SARS in Singapore (given by the Office of the President, Republic of Singapore), 2003